1-20 of 97
renal function
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis

Fady T. Botros, Hertzel C. Gerstein, Raleigh Malik, Claudia Nicolay, Anastasia Hoover, Ibrahim Turfanda, Helen M. Colhoun, Jonathan E. Shaw
Journal: Diabetes Care
Diabetes Care 2023;46(8):1524–1530
https://doi.org/10.2337/dc23-0231
Published: 21 June 2023
View article titled, Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis
Open the PDF for Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis in another window
Journal Articles

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis

Hiddo J.L. Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L. Duffin, Zhengyu Yang, Russell J. Wiese, Jonathan M. Wilson, Andrea Hemmingway, David Z.I. Cherney, Katherine R. Tuttle
Journal: Diabetes Care
Diabetes Care 2023;46(8):1501–1506
https://doi.org/10.2337/dc23-0261
Published: 02 June 2023
View article titled, Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis
Open the PDF for Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis in another window
Journal Articles

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study

Diego Moriconi, Luca Sacchetta, Martina Chiriacò, Lorenzo Nesti, Giovanna Forotti, Andrea Natali, Anna Solini, Domenico Tricò
Journal: Diabetes Care
Diabetes Care 2023;46(4):845–853
https://doi.org/10.2337/dc22-2003
Published: 14 February 2023
View article titled, Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study
Open the PDF for Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study in another window
Journal Articles

African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes

Anastasios Mangelis, Nikolaos Fountoulakis, Antonella Corcillo, Julian Collins, Prashant Vas, Sufyan Hussain, David Hopkins, Luigi Gnudi, Stephen Thomas, Salma Ayis, Janaka Karalliedde
Journal: Diabetes Care
Diabetes Care 2022;45(9):2095–2102
https://doi.org/10.2337/dc22-0815
Published: 24 August 2022
View article titled, African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes
Open the PDF for African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes in another window
Journal Articles

Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691

Gauthier Borderie, Alice Larroumet, Laurence Baillet-Blanco, Ninon Foussard, Vincent Rigalleau
Journal: Diabetes Care
Diabetes Care 2022;45(6):e110
https://doi.org/10.2337/dc22-0337
Published: 27 May 2022
View article titled, Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Open the PDF for Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691 in another window
Journal Articles

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691

Juraj Koska, Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven
Journal: Diabetes Care
Diabetes Care 2022;45(6):e111–e112
https://doi.org/10.2337/dci22-0013
Published: 27 May 2022
View article titled, Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Open the PDF for Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691 in another window
Journal Articles

Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(3):e69
https://doi.org/10.2337/dci21-0062
Published: 04 March 2022
View article titled, Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
Open the PDF for Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41 in another window
Journal Articles

Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41

Samuel N. Heyman, Itamar Raz, Zaid Abassi
Journal: Diabetes Care
Diabetes Care 2022;45(3):e67–e68
https://doi.org/10.2337/dc21-2393
Published: 04 March 2022
View article titled, Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
Open the PDF for Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41 in another window
Journal Articles

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Juraj Koska, Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven
Journal: Diabetes Care
Diabetes Care 2022;45(3):684–691
https://doi.org/10.2337/dc21-2196
Published: 20 January 2022
View article titled, Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Open the PDF for Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in another window
Journal Articles

High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(1):35–41
https://doi.org/10.2337/dc21-1211
Published: 28 October 2021
View article titled, High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
Open the PDF for High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort in another window
Journal Articles

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database

Hajime Nagasu, Yuichiro Yano, Hiroshi Kanegae, Hiddo J.L. Heerspink, Masaomi Nangaku, Yosuke Hirakawa, Yuka Sugawara, Naoki Nakagawa, Yuji Tani, Jun Wada, Hitoshi Sugiyama, Kazuhiko Tsuruya, Toshiaki Nakano, Shoichi Maruyama, Takashi Wada, Kunihiro Yamagata, Ichiei Narita, Kouichi Tamura, Motoko Yanagita, Yoshio Terada, Takashi Shigematsu, Tadashi Sofue, Takafumi Ito, Hirokazu Okada, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Seiji Itano, Akira Nishiyama, Eiichiro Kanda, Kohjiro Ueki, Naoki Kashihara
Journal: Diabetes Care
Diabetes Care 2021;44(11):2542–2551
https://doi.org/10.2337/dc21-1081
Published: 18 October 2021
View article titled, Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
Open the PDF for Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database in another window
Journal Articles

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial

Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar, Anne C. Hesp, Peter J. Greasley, Cecilia Karlsson, Ann Hammarstedt, Niki Arya, Daniël H. van Raalte, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2021;44(2):440–447
https://doi.org/10.2337/dc20-2604
Published: 14 December 2020
View article titled, Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial
Open the PDF for Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial in another window
Journal Articles

Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study

Raija Lithovius, Valma Harjutsalo, Stefan Mutter, Daniel Gordin, Carol Forsblom, Per-Henrik Groop
Journal: Diabetes Care
Diabetes Care 2020;43(8):1885–1892
https://doi.org/10.2337/dc20-0170
Published: 22 May 2020
View article titled, Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study
Open the PDF for Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study in another window
Journal Articles

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Vlado Perkovic, Robert Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Bernard Zinman, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Maximillian von Eynatten, Jyothis T. George, Odd Erik Johansen, Christoph Wanner
Journal: Diabetes Care
Diabetes Care 2020;43(8):1803–1812
https://doi.org/10.2337/dc20-0279
Published: 22 May 2020
View article titled, Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
Open the PDF for Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial in another window
Journal Articles

Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas

Patricia Y. Chu, Amber J. Hackstadt, Jonathan Chipman, Marie R. Griffin, Adriana M. Hung, Robert A. Greevy, Jr., Carlos G. Grijalva, Tom Elasy, Christianne L. Roumie
Journal: Diabetes Care
Diabetes Care 2020;43(7):1462–1470
https://doi.org/10.2337/dc19-2391
Published: 23 April 2020
View article titled, Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas
Open the PDF for Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas in another window
Journal Articles

Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits

Vasileios Liakopoulos, Stefan Franzén, Ann-Marie Svensson, Naveed Sattar, Mervete Miftaraj, Staffan Björck, Johan Ottosson, Ingmar Näslund, Soffia Gudbjörnsdottir, Björn Eliasson
Journal: Diabetes Care
Diabetes Care 2020;43(6):1276–1284
https://doi.org/10.2337/dc19-1703
Published: 09 March 2020
View article titled, Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits
Open the PDF for Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits in another window
Includes: Supplementary data
Journal Articles

Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Oyunchimeg Buyadaa, Dianna J. Magliano, Agus Salim, Digsu N. Koye, Jonathan E. Shaw
Journal: Diabetes Care
Diabetes Care 2020;43(1):122–129
https://doi.org/10.2337/dc19-1438
Published: 03 December 2019
View article titled, Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes
Open the PDF for Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakuboniene, Brian Katona, Yuliya Lokhnygina, Renato D. Lopes, Aldo P. Maggioni, Peter Ohman, Tsvetalina Tankova, George L. Bakris, Adrian F. Hernandez, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2020;43(2):446–452
https://doi.org/10.2337/dc19-1065
Published: 22 November 2019
View article titled, Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
Open the PDF for Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial in another window
Includes: Supplementary data
Journal Articles

Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Wenrong Chen, Dan Lu, Zuoming Huang, Lin Xiao
Journal: Diabetes Care
Diabetes Care 2019;42(12):e187
https://doi.org/10.2337/dc19-1321
Published: 12 November 2019
View article titled, Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094
Open the PDF for Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094 in another window
Journal Articles

Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Sascha Pilemann-Lyberg, Tine Willum Hansen, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2019;42(12):e188
https://doi.org/10.2337/dci19-0037
Published: 12 November 2019
View article titled, Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094
Open the PDF for Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094 in another window